Today before the opening
bell, Actinium announced that it has engaged the investor relations services of
MissionIR. Through its network of investor-oriented sites and full suite of
investor awareness services, MissionIR broadens the influence of publicly
traded companies and enhances their ability to attract growth capital as well
as improve shareholder value.
“Actinium is wrapping up a
year of tremendous progress in the development of its cancer treatment
candidates, and is on the cusp of initiating additional clinical trials,”
stated Sherri Franklin, Director of Marketing at MissionIR. “MissionIR is
pleased to partner with the Company as it starts off a new year of advances
with a firm stance and high potential in the biotech industry.”
“We’re moving closer to the
commercialization of our cancer drugs, and want to increase visibility in the
investment community and enhance communication with our existing shareholders
along the way,” Dr. Kaushik J. Dave, President and CEO of Actinium, stated.
“Engaging a full-service investor relations firm will help us develop and
implement a strategic investor relations campaign to reach this goal. MissionIR
is providing a much-needed service in the small-cap markets.”
Actinium is a New York-based
pharmaceuticals company that is developing innovative immunotherapeutic
solutions for treatment of advanced cancers. Specifically, the company
harnesses its proprietary platform for the therapeutic utilization of alpha
particle emitting actinium-225 and bismuth-213 radiopharmaceuticals, in
association with monoclonal antibodies, for development of alpha particle
immunotherapeutics.
Actinium intends to develop
its cancer treatment products through clinical trials and then intends to
partner each drug for completion of development and commercialization with an
appropriate third party. In working toward this objective, the company aims to
increase brand awareness.
For more information about
Actinium, its developments, and its progress, please visit:
www.actiniumpharmaceuticals.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
